Today's guest is Aktana Chairman and CEO David Ehrlich. Aktana is an AI vendor that helps life science commercial teams go to market with their products. On the AI in Business podcast, David talks about the challenges that marketing and product teams face in getting pharmaceuticals in the marketplace and where these challenges overlap with broader industry applications in banking and retail. Later, he and Emerj CEO Daniel Faggella discuss where AI adds value to the process in unique use cases and what gives life science commercial teams the highest chances of success in adopting AI. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related